jun liu

jun liu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2021 in Gut Pathogens
Verified
Journal Article
Open access
PDF file
YWYijia Wang
Yijia Wang
XWXuehua Wan
Xuehua Wan
XWXiaojing Wu
Xiaojing Wu
CZChunze Zhang
Chunze Zhang
JLjun liu
jun liu
SHShaobin Hou
Shaobin Hou
Background: Inflammatory bowel disease caused by microbial dysbiosis is an important factor contributing to colorectal cancer (CRC) initiation. The ‘driver-passenger’ model in human gut microbial dysbiosis suggests that ‘driver’ bacteria may colonize with low relative abundance on tumor site but persistently induce chronic change in normal intestinal epithelium and initiate CRC. They are gradually replaced by ‘passenger’ bacteria later on, due to their low adaptability to the on-tumor site niche.Results: To reveal site-specific bacterial taxon markers in CRC patients, we analyzed the gut mucosal microbiome of 75 paired samples of on-tumor and tumor-adjacent sites, 75 off-tumor sites, and 26 healthy controls. Linear discriminant analysis of relative abundance profiles revealed unique bacterial taxon distribution correlated with specific tumor sites, withEubacteriumhaving the distribution characteristic of potential driver bacteria. We further show thatEubacterium rectaleendotoxin activates the transcription factor NF-κΒ, which regulates multiple aspects of innate and adaptive immune responses in normal colon epithelial cells. Unlike the ‘passenger’ bacteriumFusobacterium nucleatum,E. rectalepromotes dextran sodium sulfate-induced colitis in Balb/c mice.Conclusions: Our findings reveal thatE. rectalefunctions as a ‘driver’ bacterium and contributes to cancer initiation via promoting inflammation.

1 November 2020 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
YWYijia Wang
Yijia Wang
CZChunze Zhang
Chunze Zhang
SHShaobin Hou
Shaobin Hou
XWXiaojing Wu
Xiaojing Wu
JLjun liu
jun liu
XWXuehua Wan
Xuehua Wan
Introduction: Besides genetic and epigenetic alterations that lead to carcinogenesis and development of colorectal cancer (CRC), intestinal microbiomes are recently recognized to play a critical role in CRC progression. The abundant species associated with human CRC have been proposed for their roles in promoting tumorigenesis. However, a recent “driver-passenger” model suggests that these CRC-associated species with high relative abundances may be passenger bacteria that take advantage of the tumor environment instead of initiating CRC, whereas the driver species that initiate CRC have been replaced by passenger bacteria due to the alteration of the intestinal niche. Methods: Here, to reveal potential driver and passenger bacteria during CRC progression, we compare the gut mucosal microbiomes of 75 triplet-paired CRC samples collected from on-tumor site, adjacent-tumor site, and off-tumor site, and 26 healthy controls. Results: Our analyses revealed potential driver bacteria in four genera and two families, and potential passenger bacteria in 14 genera or families. Bacillus, Bradyrhizobium, Methylobacterium, Streptomyces, Intrasporangiaceae and Sinobacteraceae were predicted to be potential driver bacteria. Moreover, 14 potential passenger bacteria were identified and divided into five groups. Group I passenger bacteria contain Fusobacterium, Campylobacter, Streptococcus, Schwartzia, and Parvimonas. Group II passenger bacteria contain Dethiosulfatibacter, Selenomonas, Peptostreptococus, Leptotrichia. Group III passenger bacteria contain Granulicatella. Group IV passenger bacteria contain Shewanella, Mogibacterium, and Eikenella. Group V passenger bacteria contain Anaerococus. Co-occurrence network analysis reveals a low correlation relationship between driver and passenger bacteria in CRC patients compared with healthy controls. Discussion: These driver and passenger species may serve as bio-marker species for screening cohorts with high risk to initiate CRC or patients with CRC, respectively. Further functional studies will help understand the roles of driver and passenger bacteria in CRC initiation and development.

28 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YWYijia Wang
Yijia Wang
CZChunze Zhang
Chunze Zhang
SZShiwu Zhang
Shiwu Zhang
ZZZhenying Zhao
Zhenying Zhao
JWJiawen Wang
Jiawen Wang
SHShaobin Hou
Shaobin Hou
Taxol, a first-line anti-tumour drug, has low effectiveness against colorectal cancer. Combination with other agents is an effective strategy to enhance Taxol cytotoxicity. Kanglaite injection is an extract from Coix lacryma-jobi seed and is usually combined with other agents to treat cancer. The aim of this study was to investigate the treatment effect of Taxol combined with Kanglaite on colorectal cancer cell lines. Kanglaite pretreatment followed by Taxol treatment was found to show the best synergism among all combination strategies. This combination also resulted in the smallest tumour volume in a Balb/c mice model. Kanglaite inhibited the expression of nuclear factor (NF)-κΒ and upregulated that of connexin 43, both of which sensitized cancer cells to Taxol. Moreover, Kanglaite increased many cellular variations caused by Taxol, including tubulin polymerization, caspase-3 cleavage, and upregulated expression of survivin and cyclin B1. These results suggest that Kanglaite pretreatment may increase the effect of Taxol on colorectal cancer.

1 February 2018 in Molecular and Cellular Probes
Verified
Journal Article
Closed access
GSGuiling Shi
Guiling Shi
YWYijia Wang
Yijia Wang
CZChunze Zhang
Chunze Zhang
ZZZhenying Zhao
Zhenying Zhao
XSXiuying Sun
Xiuying Sun
JLjun liu
jun liu

16 June 2023 in Clinical & Experimental Metastasis
Verified
Journal Article
Closed access
PDF file
YLYongming Lv
Yongming Lv
WWWenhong Wang
Wenhong Wang
YLYanfei Liu
Yanfei Liu
BYBen Yi
Ben Yi
TCTianhao Chu
Tianhao Chu
YWYijia Wang
Yijia Wang

20 April 2016 in The Analyst
Verified
Journal Article
Closed access
PDF file
YWYijia Wang
Yijia Wang
SZShiwu Zhang
Shiwu Zhang
CZChunze Zhang
Chunze Zhang
ZZZhenying Zhao
Zhenying Zhao
XZXiaoli Zheng
Xiaoli Zheng
XYXiaocong Yuan
Xiaocong Yuan
The real-time and label free detection abilities of surface plasmon resonance (SPR) biosensors provide a way of evaluating the influence of some genes’ expression on anti-tumor drug cytotoxicity.